The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Nurix Therapeutics, Inc(NASDAQ:NRIX)


Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader with immunomodul...
Website: http://www.nurixtx.com
Founded: 2009
Full Time Employees: 122
CEO: Arthur T. Sands
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Nurix Therapeutics Days Payable Outstanding ttm (DPO)
Nurix Therapeutics Days Receivable Outstanding ttm (DSO)
Nurix Therapeutics Op Cashflow Per Share ttm
Nurix Therapeutics Free Cashflow Per Share ttm
Nurix Therapeutics Cash Per Share ttm
Nurix Therapeutics P/S ratio ttm
Nurix Therapeutics (GAAP) P/E ratio ttm
Nurix Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.